Literature DB >> 25832411

PLD3 in non-familial Alzheimer's disease.

Stefanie Heilmann1, Dmitriy Drichel2, Jordi Clarimon3, Victoria Fernández4, André Lacour2, Holger Wagner5, Mathias Thelen5, Isabel Hernández4, Juan Fortea3, Montserrat Alegret4, Rafael Blesa3, Ana Mauleón4, Maitée Rosende Roca4, Johannes Kornhuber6, Oliver Peters7, Reinhard Heun5, Lutz Frölich8, Michael Hüll9, Michael T Heneka10, Eckart Rüther11, Steffi Riedel-Heller12, Martin Scherer13, Jens Wiltfang11, Frank Jessen14, Tim Becker15, Lluís Tárraga4, Mercè Boada4, Wolfgang Maier16, Alberto Lleó3, Agustin Ruiz4, Markus M Nöthen1, Alfredo Ramirez17.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832411     DOI: 10.1038/nature14039

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  INTERSNP: genome-wide interaction analysis guided by a priori information.

Authors:  Christine Herold; Michael Steffens; Felix F Brockschmidt; Max P Baur; Tim Becker
Journal:  Bioinformatics       Date:  2009-10-16       Impact factor: 6.937

2.  PLD3 gene variants and Alzheimer's disease.

Authors:  Basavaraj V Hooli; Christina M Lill; Kristina Mullin; Dandi Qiao; Christoph Lange; Lars Bertram; Rudolph E Tanzi
Journal:  Nature       Date:  2015-04-02       Impact factor: 49.962

3.  PLD3 and sporadic Alzheimer's disease risk.

Authors:  Jean-Charles Lambert; Benjamin Grenier-Boley; Céline Bellenguez; Florence Pasquier; Dominique Campion; Jean-Francois Dartigues; Claudine Berr; Christophe Tzourio; Philippe Amouyel
Journal:  Nature       Date:  2015-04-02       Impact factor: 49.962

4.  High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease.

Authors:  C Pottier; D Hannequin; S Coutant; A Rovelet-Lecrux; D Wallon; S Rousseau; S Legallic; C Paquet; S Bombois; J Pariente; C Thomas-Anterion; A Michon; B Croisile; F Etcharry-Bouyx; C Berr; J-F Dartigues; P Amouyel; H Dauchel; C Boutoleau-Bretonnière; C Thauvin; T Frebourg; J-C Lambert; D Campion
Journal:  Mol Psychiatry       Date:  2012-04-03       Impact factor: 15.992

5.  Prediction of dementia in primary care patients.

Authors:  Frank Jessen; Birgitt Wiese; Horst Bickel; Sandra Eiffländer-Gorfer; Angela Fuchs; Hanna Kaduszkiewicz; Mirjam Köhler; Tobias Luck; Edelgard Mösch; Michael Pentzek; Steffi G Riedel-Heller; Michael Wagner; Siegfried Weyerer; Wolfgang Maier; Hendrik van den Bussche
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

6.  Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.

Authors:  Agustín Ruiz; Oriol Dols-Icardo; María J Bullido; Pau Pastor; Eloy Rodríguez-Rodríguez; Adolfo López de Munain; Marian M de Pancorbo; Jordi Pérez-Tur; Victoria Alvarez; Anna Antonell; Jesús López-Arrieta; Isabel Hernández; Lluís Tárraga; Mercè Boada; Alberto Lleó; Rafael Blesa; Ana Frank-García; Isabel Sastre; Cristina Razquin; Sara Ortega-Cubero; Elena Lorenzo; Pascual Sánchez-Juan; Onofre Combarros; Fermín Moreno; Ana Gorostidi; Xabier Elcoroaristizabal; Miquel Baquero; Eliecer Coto; Raquel Sánchez-Valle; Jordi Clarimón
Journal:  Neurobiol Aging       Date:  2013-09-13       Impact factor: 4.673

7.  Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network.

Authors:  Johannes Kornhuber; Klaus Schmidtke; Lutz Frolich; Robert Perneczky; Stefanie Wolf; Harald Hampel; Frank Jessen; Isabella Heuser; Oliver Peters; Markus Weih; Holger Jahn; Christian Luckhaus; Michael Hüll; Hermann-Josef Gertz; Johannes Schröder; Johannes Pantel; Otto Rienhoff; Susanne A Seuchter; Eckart Rüther; Fritz Henn; Wolfgang Maier; Jens Wiltfang
Journal:  Dement Geriatr Cogn Disord       Date:  2009-04-01       Impact factor: 2.959

8.  An evaluation of statistical approaches to rare variant analysis in genetic association studies.

Authors:  Andrew P Morris; Eleftheria Zeggini
Journal:  Genet Epidemiol       Date:  2010-02       Impact factor: 2.135

9.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

10.  Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene.

Authors:  A Ruiz; S Heilmann; T Becker; I Hernández; H Wagner; M Thelen; A Mauleón; M Rosende-Roca; C Bellenguez; J C Bis; D Harold; A Gerrish; R Sims; O Sotolongo-Grau; A Espinosa; M Alegret; J L Arrieta; A Lacour; M Leber; J Becker; A Lafuente; S Ruiz; L Vargas; O Rodríguez; G Ortega; M-A Dominguez; R Mayeux; J L Haines; M A Pericak-Vance; L A Farrer; G D Schellenberg; V Chouraki; L J Launer; C van Duijn; S Seshadri; C Antúnez; M M Breteler; M Serrano-Ríos; F Jessen; L Tárraga; M M Nöthen; W Maier; M Boada; A Ramírez
Journal:  Transl Psychiatry       Date:  2014-02-04       Impact factor: 6.222

View more
  26 in total

1.  Cruchaga & Goate reply.

Authors:  Carlos Cruchaga; Alison M Goate
Journal:  Nature       Date:  2015-04-02       Impact factor: 49.962

2.  PLD3 gene variants and Alzheimer's disease.

Authors:  Basavaraj V Hooli; Christina M Lill; Kristina Mullin; Dandi Qiao; Christoph Lange; Lars Bertram; Rudolph E Tanzi
Journal:  Nature       Date:  2015-04-02       Impact factor: 49.962

3.  PLD3 and sporadic Alzheimer's disease risk.

Authors:  Jean-Charles Lambert; Benjamin Grenier-Boley; Céline Bellenguez; Florence Pasquier; Dominique Campion; Jean-Francois Dartigues; Claudine Berr; Christophe Tzourio; Philippe Amouyel
Journal:  Nature       Date:  2015-04-02       Impact factor: 49.962

4.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

Review 5.  Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Authors:  Neha Raghavan; Giuseppe Tosto
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-21       Impact factor: 5.081

6.  Reply: POLR3A variants in hereditary spastic paraplegia and ataxia.

Authors:  Martina Minnerop; Delia Kurzwelly; Tim W Rattay; Dagmar Timmann; Holger Hengel; Matthis Synofzik; Claudia Stendel; Rita Horvath; Rebecca Schüle; Alfredo Ramirez
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

Review 7.  Physiological and pathophysiological roles for phospholipase D.

Authors:  Rochelle K Nelson; Michael A Frohman
Journal:  J Lipid Res       Date:  2015-04-29       Impact factor: 5.922

Review 8.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

9.  ABCA7 rare variants and Alzheimer disease risk.

Authors:  Kilan Le Guennec; Gaël Nicolas; Olivier Quenez; Camille Charbonnier; David Wallon; Céline Bellenguez; Benjamin Grenier-Boley; Stéphane Rousseau; Anne-Claire Richard; Anne Rovelet-Lecrux; Delphine Bacq; Jean-Guillaume Garnier; Robert Olaso; Anne Boland; Vincent Meyer; Jean-François Deleuze; Philippe Amouyel; Hans Markus Munter; Guillaume Bourque; Mark Lathrop; Thierry Frebourg; Richard Redon; Luc Letenneur; Jean-François Dartigues; Florence Pasquier; Adeline Rollin-Sillaire; Emmanuelle Génin; Jean-Charles Lambert; Didier Hannequin; Dominique Campion
Journal:  Neurology       Date:  2016-04-01       Impact factor: 9.910

Review 10.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.